By 2017, the stem cell market in India is estimated to worth $600 million and the Government of India is focusing on to become a global leader in stem cells research and therapy. The stem cells research is saving patient lives in India. India has nine major stem cells research organizations and the field is gaining its ground. India is in the process of strengthening the regulatory structure for drugs, medical devices, and is also looking at a robust guideline for stem cell therapy. Learn the different Entry Strategies for the foreign investors who enter into the Indian market.

“The Drug Controller General of India (DCGI)’s approval for clinical trials of stem cell based drugs is proving to win. Many global stem cell players are keen to work, and pursue their clinical trial in India” said an Official of Health Ministry. An understanding regarding the documents required for doing clinical trials in India would be available in our Morulaa blog section. A recent report states that the stem cells market values at $26.23 billion in 2013 and is expected to be worth $119.52 billion by 2019 clocking at a growth rate of 24.2%. READ ALSO: Healthcare market in India.